Precigen

January 02, 2019

Pharma news over the Christmas period

If the recent performance of biotech stocks prompted you to pull down the shutters until the New Year celebrations subsided here’s what you might have missed.

August 08, 2018

Is Spark really worth less than Crispr Therapeutics?

June 19, 2018

Ziopharm stalls its CAR yet again

March 06, 2018

Cytokine therapy focus – riding on Nektar’s coattails

December 14, 2017

Ash 2017 winners and losers – Déjà vu

November 02, 2017

Ash 2017 preview – Blueprint and Stemline celebrate

January 09, 2017

Interview – German Merck unveils its secret weapon

December 23, 2016

Courtesy of Intrexon, a cautionary tale for trusting investors

December 10, 2015

Winners and losers – An ASH bloodbath